Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users.

about

Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users.

Item

http://www.wikidata.org/entity/Q40809341

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users.

@en

type

Item

label

Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users.

@en

prefLabel

Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users.

@en

P1476

Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users

@en

P2093

B Cameron

http://www.w3.org/2001/XMLSchema#string

F Luciani

http://www.w3.org/2001/XMLSchema#string

HITS-p investigators

http://www.w3.org/2001/XMLSchema#string

M M Mina

http://www.w3.org/2001/XMLSchema#string

U Vollmer-Conna

http://www.w3.org/2001/XMLSchema#string

P2860

Subsets of human natural killer cells and their regulatory effects

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

Functions of natural killer cells

NK cell recognition

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort

Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner

Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses.

Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.

P304

464-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVH.12511

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew R. Lloyd

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292677454

http://www.w3.org/2001/XMLSchema#string

P698

26833632

http://www.w3.org/2001/XMLSchema#string